P gene variants and response to lamivudine in patients with chronic hepatitis B.

被引：0
|
作者：
Buti, M
Rodriguez-Frias, F
Eva, CD
Cotrina, M
Esteban, R
Guardia, J
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
[2] GLAXO WELLCOME, Madrid, Spain
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1942
引用
收藏
页码：646A / 646A
页数：1
相关论文
共 50 条
  • [31] Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B
    Lai, CL
    Dienstag, J
    Schiff, E
    Leung, NWY
    Atkins, M
    Hunt, C
    Brown, N
    Woessner, M
    Boehme, R
    Condreay, L
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (06) : 687 - 696
  • [32] Predictive value of hepatitis B virus cccDNA in PBMC of response to lamivudine therapy in patients with chronic hepatitis B
    Guo, Hao-Yu
    Tan, De-Ming
    Xu, Xu-Wen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A117 - A118
  • [33] Lamivudine for chronic hepatitis B
    不详
    Drugs & Therapy Perspectives, 2000, 15 (4) : 1 - 5
  • [34] Lamivudine plasma levels in chronic hepatitis B patients
    Wolters, LMM
    Geerlings, CJC
    van Dijk, L
    Niesters, HGM
    Vulto, AG
    de Man, RA
    NETHERLANDS JOURNAL OF MEDICINE, 2003, 61 (01): : 9 - 13
  • [35] Continued lamivudine therapy in patients with chronic hepatitis B
    Kumada, H
    INTERVIROLOGY, 2003, 46 (06) : 377 - 387
  • [36] Telbivudine versus lamivudine in patients with chronic hepatitis B
    Lai, Ching-Lung
    Gane, Edward
    Liaw, Yun-Fan
    Hsu, Chao-Wei
    Thongsawat, Satawat
    Wang, Yuming
    Chen, Yagang
    Heathcote, E. Jenny
    Rasenack, Jens
    Bzowej, Natalie
    Naoumov, Nikolai V.
    Di Bisceglie, Adrian M.
    Zeuzem, Stefan
    Moon, Young Myoung
    Goodman, Zachary
    Chao, George
    Constance, Barbara Fielman
    Brown, Nathaniel A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (25): : 2576 - 2588
  • [37] Treatment with lamivudine of Venezuelan children with chronic hepatitis B. Preliminary report.
    Pierre, R
    Lopez, C
    Rondon, L
    Machado, I
    Mendez, E
    Leon, K
    Suarez, A
    Garassini, ME
    HEPATOLOGY, 2001, 34 (04) : 625A - 625A
  • [38] Efficacy of long term lamivudine therapy in HBeAg negative chronic hepatitis B.
    Dimou, E
    Papatheodoridis, GV
    Laras, A
    Hadziyannis, SJ
    GASTROENTEROLOGY, 2000, 118 (04) : A1004 - A1004
  • [39] Beneficial effects of corticosteroid priming prior to lamivudine therapy in chronic hepatitis B.
    Liaw, YF
    Chien, RN
    Tsai, SL
    Yeh, CT
    Chu, CM
    HEPATOLOGY, 1999, 30 (04) : 348A - 348A
  • [40] Disappearance of HBcAG in the liver is a clinically useful marker for discontinuation of lamivudine therapy in patients with chronic hepatitis B.
    Watanabe, H
    Izumi, N
    Simizu, M
    Noguchi, O
    Hoshino, Y
    Uchihara, M
    Miyake, S
    Sakai, T
    Enomoto, N
    Sato, C
    GASTROENTEROLOGY, 1998, 114 (04) : A1363 - A1363
12345